Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Molecular Biotechnology|May 13, 2024
Marine-Derived Cytosine Arabinoside (Ara-C) Inhibits Biofilm Formation by Inhibiting PEL Operon Proteins (Pel A and Pel B) of Pseudomonas aeruginosa: An In Silico ApproachSusmita Datta, Vishal Singh, Soma Nag, et al.Environmental Science and Pollution Research International|June 18, 2017
Biosorption of chromium (VI) from aqueous solutions and ANN modellingSoma Nag, Abhijit Mondal, Nirjhar Bar, et al.Environmental Science and Pollution Research International|June 30, 2022
An eco-friendly removal of Cd(II) utilizing banana pseudo-fibre and Moringa bark as indigenous green adsorbent and modelling of adsorption by artificial neural networkJoydeep Das, Rahul Saha, Harjeet Nath, et al.Journal of Physics. Condensed Matter : an Institute of Physics Journal|March 10, 2011
Crack patterns in desiccating clay-polymer mixtures with varying compositionSoma Nag, Suparna Sinha, Supti Sadhukhan, et al.Biodegradation|May 21, 2026
Plastic pollution and its global environmental impacts: a comprehensive review of microbial biodegradation mechanisms, plastic-degrading enzymes, emerging biotechnological strategies and artificial intelligence-driven approaches for sustainable plastic waste managementRahel Debbarma, Bibhab Kumar Lodh, Tarun Kanti Bandyopadhyay, et al.Clinical & Developmental Immunology|July 19, 2013
Microglia play a major role in direct viral-induced demyelinationDhriti Chatterjee, Kaushiki Biswas, Soma Nag, et al.Biomed Research International|October 2, 2013
Different mechanisms of inflammation induced in virus and autoimmune-mediated models of multiple sclerosis in C57BL6 miceAbhinoy Kishore, Anurag Kanaujia, Soma Nag, et al.The American Journal of Managed Care|October 25, 2002
Growth in use of lipid-lowering therapies: are we targeting the right patients?Robert W Dubois, Charles M Alexander, Sally Wade, et al.International Journal of Bipolar Disorders|February 18, 2026
Views on an antipsychotic regimen administered once every 2 months: a qualitative interview study of people living with bipolar I disorder, caregivers, and prescribers in the USA and CanadaMauricio Tohen, Murat Yildirim, Stephanie Loomer, et al.Current Medical Research and Opinion|November 21, 2025
Understanding patient, caregiver, and prescriber preferences for an antipsychotic regimen administered once every 2 months for schizophrenia or bipolar I disorder: a qualitative interview study in North AmericaRoger S McIntyre, Murat Yildirim, Stephanie Loomer, et al.Pageof 3